Cover Page

Cite item


Despite of arterial hypertension high prevalence and its complications in Mongolia, the epidemiology and structure of hypertension-mediated organ damage remains insufficiently studied. Aim. To assess elaboration level of the problem of AH-associated hypertension-mediated organ damage in Mongolia. Materials and methods. Leading international guidelines and recommendations, reviews, meta-analyzes, randomized controlled, population-based research and Mongolian scientific papers with different evidential value, related to hypertension-mediated organ damage were analyzed. Results and discussion. In developed countries, hypertension-mediated organ damage structure and their contribution to total cardiovascular risk stratification in patients with hypertension is well studied. In 2018 ESC/ESH Guidelines for the management of arterial hypertension hypertension-mediated organ damage criteria were only slightly extended. Data on arterial hypertension epidemiology, including hypertension-mediated organ damage structure, in Mongolian population, mainly obtained from ethnic Mongols living in the territory of Inner Mongolia and other provinces of China, or in international studies with Mongolia participation. Directly in Mongolia, hypertension-mediated organ damage were studied in small samples; a systemic epidemiological analysis of hypertension-mediated organ damage was not carried out. Conclusions. Given arterial hypertension significance in Mongolia and insufficient scientific elaboration of problem, population studies are needed to clarify hypertension-mediated organ damage prevalence and structure in order for improving arterial hypertension management.

About the authors

T. M. Maksikova

Irkutsk State Medical University

Author for correspondence.
SPIN-code: 9726-2314
Irkutsk, Russia

Ts. Barsuren

National center for the study of infectious diseases

Ulan Bator, Mongolia

A. N. Kalyagin

Irkutsk State Medical University

SPIN-code: 6737-0285
Irkutsk, Russia

E. B. Babanskaya

Irkutsk State Academy of Postgraduate education

SPIN-code: 7117-0201
Irkutsk, Russia


  1. A global brief on Hypertension. Silent killer, global public health crisis. Geneva: WHO; 2013, 39 p.
  2. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018 Nov 10;392(10159):1923-1994. doi: 10.1016/S0140-6736 (18)32225-6.
  3. Mendis Sh., Puska P., Norrving B., editors. Global Atlas on cardiovascular disease prevention and control. Geneva: World Health Organization; 2011. 155 p.
  4. Mendis Sh., lead author. Global status report on noncommunicable diseases. 2014. Geneva: WHO. 2014. 280 p.
  5. World Health Organization - Noncommunicable Diseases (NCD) Country Profiles, 2018 [Online]. 2018 [cited 2018 Nov 1]. Available from: nmh/countries/mng_en.pdf?ua=1.
  6. Mancia G., Chairman. 2003 European Society of Hypertension - European Society of Cardiology guidelines for the management of arterial hypertension. Journal of Hypertension 2003; 21(6):1011-1053.
  7. Mancia G., Backer G., Co-Chairpersons. 2007 Guidelines for the Management of Arterial Hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Journal of Hypertension 2007; 25 (6):1105-1187.
  8. Mancia G., Fagard R., co-chairs. 2013 ESH/ESC Guidelines for the management of arterial hypertension. Journal of Hypertension. 2013. Т. 31. № 7. С. 1281-1357. doi: 10.1093/euroheartj/eht151.
  9. Williams B., Mancia G., Spiering W., Agabiti Rosei E., Azizi M., Burnier M., Clement D., Coca A., De Simone G., Dominiczak A., Kahan T., Mahfoud F., Redon J., Ruilope L., Zanchetti A., Kerins M., Kjeldsen S., Kreutz R., Laurent S., Lip GYH, McManus R., Narkiewicz K., Ruschitzka F., Schmieder R., Shlyakhto E., Tsioufis K., Aboyans V., Desormais I. 2018 ESC/ESH Guidelines for the management of arterial hypertension European Heart Journal, Volume 39, Issue 33, 1 September 2018, P. 3021-3104,
  10. Nedogoda S.V., Baranova E.I., Kabalava Zh.D., Konradi A.O. Algorithms for the management of patients with arterial hypertension. St. Petersburg, 2015. 54 с. (in Russian).
  11. Venketasubramanian N., Yoon B.W., Pandian J., Navarro J.C. Stroke Epidemiology in South, East, and South-East Asia: A Review. Journal of Stroke 2017; 19(3):286-294.
  12. GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017; 390:1151-1210.
  13. Safar M.E., Levy B.I., Struijker-Boudier H. Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation 2003; 107:2864-2869.
  14. Staessen J.A., Fagard R., Thijs L., Celis H., Arabidze G.G., Birkenhager W.H., et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997; 350:757-764.
  15. Arima H., Murakami Y., Lam T.H., Kim H.C., Ueshima H., Woo J., Suh I., Fang X., Woodward M. Asia Pacific Cohort Studies Collaboration. Effects of prehypertension and hypertension subtype on cardiovascular disease in the Asia-Pacific Region. Hypertension. 2012 Jun; 59(6):1118-23. doi: 10.1161/ HYPERTENSIONAHA.111.187252.
  16. Li H., Kong F., Xu J., Zhang M., Wang A., Zhang Y. Hypertension subtypes and risk of cardiovascular diseases in a Mongolian population, inner Mongolia, China. Clin Exp Hypertens. 2016;38(1):39-44. doi: 10.3109/ 10641963.2015.1060981. Epub 2015 Aug 13.
  17. Li J., Xu C., Sun Z., Zheng L., Li J., Zhang D., Zhang X., Liu S., Zhao F., Hu D., Sun Y. Prevalence and risk factors for isolated untreated systolic hypertension in rural Mongolian and Han populations. Acta Cardiol. 2008 Jun; 63(3):389-93.
  18. Reichek N., Devereux R.B. Left ventricular hypertrophy: relationship of anatomic, echocardiographic and electrocardiographic findings. Circulation 1981; 63:1391-1398.
  19. Wilbert S. Aronow. Hypertension and left ventricular hypertrophy // Ann Transl Med. 2017. Vol. 5. № 15. Р. 310. doi: 10.21037/atm.2017.06.14 33.
  20. Levy D., Salomon M., D’Agostino R.B., Belanger A.J., Kannel W.B. Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. Circulation 1994; 90: 1786-1793.
  21. Bang C.N., Devereux R.B., Okin P.M. Regression of electrocardiographic left ventricular hypertrophy or strain is associated with lower incidence of cardiovascular morbidity and mortality in hypertensive patients independent of blood pressure reduction. - A LIFE review. J Electrocardiol. 2014 Sep-Oct;47(5):630-5. doi: 10.1016/j.jelectrocard.2014.07.003.
  22. Okin P.M., Devereux R.B., Jern S., Kjeldsen S.E., Julius S., Nieminen M.S., et al. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events. JAMA 2004; 292:2343-2349.
  23. Barsuren Ts., Maksikova T.M., Kalyagin A.N., Babanskaya E.B. Features of flow and management of arterial hypertension in Mongolian population. Sibirskiy meditsinskiy zhurnal (Irkutsk) 2015;(7):113-116. (in Russian).
  24. Levy D., Garrison R.J., Savage D.D., Kannel W.B., Castelli W.P. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322:1561-1566.
  25. Myagmarsuren T. Characterization of cardiometabolic risk and its relationship with myocardiс, blood vessels and kidneys damage in Mongolian organized, able-bodied population. Cand. Med. Sci [thesis]. Irkutsk. 2015. 24 p. (in Russian).
  26. Bots M.L., Hoes A.W., Koudstaal P.J., Hofman A., Grobbee D.E. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 1997; 96:1432-1437.
  27. Nambi V., Chambless L., Folsom A.R., He M., Hu Y., Mosley T., et al. Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study. J Am Coll Cardiol 2010; 55:1600-1607.
  28. Zanchetti A., Hennig M., Hollweck R., Bond G., Tang R., Cuspidi C., et al. Baseline values but nottreatment-induced changes in carotid intimamedia thickness predict incident cardiovascular events in treated hypertensive patients: findings in the European Lacidipine Study on Atherosclerosis (ELSA). Circulation 2009; 120:1084-1090.
  29. Costanzo P., Perrone-Filardi P., Vassallo E., Paolillo S., Cesarano P., Brevetti G., Chiariello M. Does carotid intima-media thickness regression predict reduction of cardiovascular events? A meta-analysis of 41 randomized trials. J Am Coll Cardiol 2010; 56:2006-2020.
  30. Lorenz M.W., Polak J.F., Kavousi M., Mathiesen E.B., Voelzke H., Tuomainen T.P., Sander D., Plichart, Catapano A.L., Robertson C.M., Kiechi S., Rundek T., Desvarieaux M., Lind L., Schmid C., Das Mahapatra P., Gao L., Wiegelbauer K., Bots M.L., Thompson S.G. PROG-IMT Study Group.Carotid intima-mediatickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): a meta-analysis of individuial participant data. Lancet. 2012 Jun 2;379(9831):2053-62. doi: 10.1016/S0140-6736 (12)60441-3. Epub 2012 Apr 27.
  31. Uurtuya S., Kotani K., Taniguchi N., Yoshioka H., Yamada T., Taniguchi N. Determinants of carotid atherosclerosis in the general Mongolian population. Ethn Dis. 2010;20:257-260.
  32. Uurtuya S., Kotani K., Taniguchi N., et al. Comparative study of atherosclerotic parameters in Mongolian and Japanese patients with hypertension and diabetes mellitus. J Atheroscler Thromb. 2010;17:181-188.
  33. Sloten T.T., Sedaghat S., Laurent S., London G.M., Pannier B., Ikram M.A., Kavousi M., Mattace-Raso F., Franco O.H., Boutouyrie P., Stehouwer C.D. Carotid stiffness is associated with incident stroke: a systematic review and individual participant data meta-analysis. J Am Coll Cardiol. 2015 Nov 10;66(19):2116-25. doi: 10.1016/j.jacc.2015.08.888.
  34. Dohi Y. The First Step Aiming at the Prevention of Hypertension and Atherosclerosis. Identification of Individuals at High Risk of Hypertension. Rinsho Byori. 2015 Nov;63(11):1303-9.
  35. Xie X., Xing Y., Li J., Hu D. An investigation of brachial-ankle pulse wave velocity among middle-aged residents in Shanghai and Inner Mongolia autonomous region. Zhonghua Nei Ke Za Zhi. 2014 May;53(5):368-70.
  36. Qu B., Liu Q., Li J. Systematic Review of Association Between Low Ankle-Brachial Index and All-Cause Cardiovascular, or Non-cardiovascular Mortality. Cell Biochem Biophys. 2015 Nov;73(2):571-575. doi: 10.1007/ s12013-015-0582-z.
  37. Forés R., Alzamora M.T., Pera G., Torán P., Urrea M., Heras A. Concordance between 3 methods of measurement the ankle-brachial index to diagnose peripheral artery disease. Med Clin (Barc). 2014 Oct 21;143(8): 335-40. doi: 10.1016/j.medcli.2013.10.029.
  38. Protasov K.V., Myagmarsuren T. Arterial hypertension in Mongolian railway transport workers: prevalence, clinical features, interconnection with cardiometabolic risk factors. Sibirskiy meditsinskiy zhurnal 2013;(6):122-126. (in Russian).
  39. Leoncini G., Viazzi F., Rosei EA., Ambrosioni E., Costa F.V., Leonetti G., Pessina A.C., Trimarco B., Volpe M., Deferrari G., Pontremoli R. Chronic kidney disease in the hypertensive patient: an overview of the I-DEMAND study. High Blood Press Cardiovasc Prev. 2011 Mar 1;18(1):31-6. doi: 10.2165/11588050-000000000-00000.
  40. Ene-Iordache B., Perico N., Bikbov B., Carminati S., Remuzzi A., Perna A., Islam N., Bravo R.F., Aleckovic-Halilovic M., Zou H., Zhang L., Gouda Z., Tchokhonelidze I., Abraham G., Mahdavi-Mazdeh M., Gallieni M., Codreanu I., Togtokh A., Sharma SK., Koirala P., Uprety S., Ulasi I., Remuzzi G. Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study. Lancet Glob Health. 2016 May;4(5):e307-19. doi: 10.1016/S2214-109X(16)00071-1.
  41. Sharma S.K., Zou H., Togtokh A., et al. Burden of CKD, proteinuria, and cardiovascular risk among Chinese, Mongolian, and Nepalese participants in the International Society of Nephrology screening programs. Am J Kidney Dis. 2010;56:915-927.
  42. Barsuren Ts., Maksikova T.M., Kalyagin A.N. Cardiovascular risk factors in citizens with arterial hypertension in Ulan Bator. Zabaykalskiy meditsinskiy vestnik 2016; (1):9-14. (in Russian).

Copyright (c) 2019 Maksikova T.M., Barsuren T., Kalyagin A.N., Babanskaya E.B.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies